• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“该行业必须不引人注目”:日本烟草公司通过吸烟研究基金会对科学和健康政策的腐蚀。

'The industry must be inconspicuous': Japan Tobacco's corruption of science and health policy via the Smoking Research Foundation.

作者信息

Iida Kaori, Proctor Robert N

机构信息

Department of Evolutionary Studies of Biosystems, SOKENDAI (The Graduate University for Advanced Studies), Hayama, Japan.

Department of History, Stanford University, Stanford, California, USA.

出版信息

Tob Control. 2018 Feb 4;27(e1):e3-e11. doi: 10.1136/tobaccocontrol-2017-053971.

DOI:10.1136/tobaccocontrol-2017-053971
PMID:29437992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6073917/
Abstract

OBJECTIVE

To investigate how and why Japan Tobacco, Inc. (JT) in 1986 established the Smoking Research Foundation (SRF), a research-funding institution, and to explore the extent to which SRF has influenced science and health policy in Japan.

METHODS

We analysed documents in the Truth Tobacco Industry Documents archive, along with recent Japanese litigation documents and published documents.

RESULTS

JT's effort to combat effective tobacco control was strengthened in the mid-1980s, following privatisation of the company. While remaining under the protection of Japan's Ministry of Finance, the semiprivatised company lost its 'access to politicos', opening up a perceived need for collaboration with global cigarette makers. One solution, arrived at through clandestine planning with American companies, was to establish a third-party organisation, SRF, with the hope of capturing scientific and medical authority for the industry. Guarded by powerful people in government and academia, SRF was launched with the covert goal of influencing tobacco policy both inside and outside Japan. Scholars funded by SRF have participated in international conferences, national advisory committees and tobacco litigation, in most instances helping the industry to maintain a favourable climate for the continued sale of cigarettes.

CONCLUSIONS

Contrary to industry claims, SRF was never meant to be independent or neutral. With active support from foreign cigarette manufacturers, SRF represents the expansion into Asia of the denialist campaign that began in the USA in 1953.

摘要

目的

调查日本烟草公司(JT)于1986年如何以及为何设立了一个研究资助机构——吸烟研究基金会(SRF),并探究SRF对日本科学和健康政策的影响程度。

方法

我们分析了“烟草行业真相文件”档案中的文件,以及近期的日本诉讼文件和已发表的文件。

结果

20世纪80年代中期,随着公司私有化,JT对抗有效控烟措施的力度加大。在仍受日本财务省保护的情况下,这家半私有化公司失去了“接触政界人士的机会”,由此产生了与全球卷烟制造商合作的明显需求。通过与美国公司秘密策划得出的一个解决方案是,成立一个第三方组织SRF,希望为该行业获取科学和医学权威。在政府和学术界有影响力的人士的庇护下,SRF成立,其隐秘目标是影响日本国内外的烟草政策。由SRF资助的学者参与了国际会议、国家咨询委员会和烟草诉讼,在大多数情况下帮助该行业维持了有利于香烟持续销售的环境。

结论

与该行业的说法相反,SRF从未打算保持独立或中立。在外国卷烟制造商的积极支持下,SRF代表了始于1953年美国的否认主义运动在亚洲的扩张。

相似文献

1
'The industry must be inconspicuous': Japan Tobacco's corruption of science and health policy via the Smoking Research Foundation.“该行业必须不引人注目”:日本烟草公司通过吸烟研究基金会对科学和健康政策的腐蚀。
Tob Control. 2018 Feb 4;27(e1):e3-e11. doi: 10.1136/tobaccocontrol-2017-053971.
2
Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.向菲利普·莫里斯公司学习:从美国烟草行业的内部文件看日本烟草公司应对烟草对健康危害证据的策略
Lancet. 2004 May 29;363(9423):1820-4. doi: 10.1016/S0140-6736(04)16310-1.
3
Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.在一项由烟草行业资助的婴儿猝死综合征评估中,关于二手烟的结论突然改变。
Pediatrics. 2005 Mar;115(3):e356-66. doi: 10.1542/peds.2004-1922.
4
Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.跨国烟草公司在欧洲对无烟烟草的利益:内部行业文件和当代行业资料分析。
PLoS Med. 2013;10(9):e1001506. doi: 10.1371/journal.pmed.1001506. Epub 2013 Sep 10.
5
Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.烟草公司影响食品和药物管理局委托医学研究所报告的努力:通过诉讼发布的文件分析。
PLoS Med. 2013;10(5):e1001450. doi: 10.1371/journal.pmed.1001450. Epub 2013 May 28.
6
ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.亚洲地区烟草行业科学家团队(ARTIST):菲利普·莫里斯公司试图在亚洲推行科学和监管议程。
Tob Control. 2004 Dec;13 Suppl 2(Suppl 2):ii118-24. doi: 10.1136/tc.2004.009001.
7
Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.烟草行业的虚假承诺及其对消费者关于吸烟健康风险的错误认知的影响。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I110-7. doi: 10.1136/tc.11.suppl_1.i110.
8
Tobacco industry argues domestic trademark laws and international treaties preclude cigarette health warning labels, despite consistent legal advice that the argument is invalid.烟草业声称国内商标法和国际条约禁止使用香烟健康警告标签,尽管有一致的法律意见认为该论点无效。
Tob Control. 2014 May;23(3):e7. doi: 10.1136/tobaccocontrol-2012-050569. Epub 2012 Nov 24.
9
Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.被销毁的文件:揭示加拿大帝国烟草公司试图隐瞒的科学。
CMAJ. 2009 Nov 10;181(10):691-8. doi: 10.1503/cmaj.080566. Epub 2009 Oct 14.
10
Courtesy and the challenges of implementing smoke-free policies in Japan.日本的礼貌与实施无烟政策面临的挑战。
Nicotine Tob Res. 2006 Apr;8(2):203-16. doi: 10.1080/14622200600576297.

引用本文的文献

1
An analysis of research grants allocated to researchers by the Smoking Research Foundation funded by Japan Tobacco Inc. in 2018.对日本烟草公司资助的吸烟研究基金会在2018年分配给研究人员的研究经费的分析。
Tob Prev Cessat. 2024 Jul 26;10. doi: 10.18332/tpc/191140. eCollection 2024.
2
The Association Between Chronic Tobacco Smoking and Brain Alterations in Schizophrenia: A Systematic Review of Magnetic Resonance Imaging Studies.慢性吸烟与精神分裂症脑改变之间的关联:磁共振成像研究的系统综述
Schizophr Bull. 2025 May 8;51(3):608-624. doi: 10.1093/schbul/sbae088.
3
Expression of Concern: Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice.关注声明:脱氢表雄酮对σ-1受体的刺激增强了嗅球切除小鼠海马齿状回的突触效能和神经发生。
PLoS One. 2023 Aug 15;18(8):e0290363. doi: 10.1371/journal.pone.0290363. eCollection 2023.
4
Unavoidable exposure to secondhand smoke in indoor places: a cross-sectional comparison to the Health Japan 21 (second term) objectives, 2022.不可避免地暴露于室内二手烟环境中:与健康日本 21(第二期)目标的横断面比较,2022 年。
Environ Health Prev Med. 2023;28:45. doi: 10.1265/ehpm.23-00055.
5
Seeking to be seen as legitimate members of the scientific community? An analysis of British American Tobacco and Philip Morris International's involvement in scientific events.寻求被视为科学界合法成员?英美烟草公司和菲利普莫里斯国际公司参与科学活动的分析。
Tob Control. 2024 Jun 20;33(4):464-471. doi: 10.1136/tc-2022-057809.
6
Expression of Concern: The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.关注声明:miR-451的低表达预示着非小细胞肺癌病例的预后更差。
PLoS One. 2023 Jan 18;18(1):e0280774. doi: 10.1371/journal.pone.0280774. eCollection 2023.
7
Expression of Concern: Trend and Risk Factors of Diverticulosis in Japan: Age, Gender, and Lifestyle/Metabolic-Related Factors May Cooperatively Affect on the Colorectal Diverticula Formation.关注声明:日本憩室病的趋势和危险因素:年龄、性别以及生活方式/代谢相关因素可能共同影响结肠憩室的形成。
PLoS One. 2023 Jan 11;18(1):e0279457. doi: 10.1371/journal.pone.0279457. eCollection 2023.
8
Expression of Concern: Characterization of intracellular calcium mobilization induced by remimazolam, a newly approved intravenous anesthetic.关注声明:瑞米唑仑(一种新获批的静脉麻醉药)诱导的细胞内钙动员的特征
PLoS One. 2023 Jan 11;18(1):e0280440. doi: 10.1371/journal.pone.0280440. eCollection 2023.
9
Expression of Concern: T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice.关注声明:T型钙通道增强剂SAK3促进野生型和淀粉样前体蛋白敲入小鼠海马体中的多巴胺和5-羟色胺释放。
PLoS One. 2023 Jan 11;18(1):e0280120. doi: 10.1371/journal.pone.0280120. eCollection 2023.
10
Expression of Concern: High Cell Density Upregulates Calcium Oscillation by Increasing Calcium Store Content via Basal Mitogen-Activated Protein Kinase Activity.关注声明:高细胞密度通过基础丝裂原活化蛋白激酶活性增加钙储存含量来上调钙振荡。
PLoS One. 2023 Jan 11;18(1):e0279475. doi: 10.1371/journal.pone.0279475. eCollection 2023.

本文引用的文献

1
Industry Speed Bumps on Local Tobacco Control in Japan? The Case of Hyogo.日本地方烟草控制中的行业阻碍?以兵库县为例。
J Epidemiol. 2015;25(7):496-504. doi: 10.2188/jea.JE20150001.
2
Mind your "smoking manners": the tobacco industry tactics to normalize smoking in Japan.注意你的“吸烟礼仪”:日本烟草行业使吸烟常态化的策略。
Kobe J Med Sci. 2013 Nov 9;59(4):E132-40.
3
Kanagawa, Japan's tobacco control legislation: a breakthrough?日本神奈川县的烟草控制立法:一次突破?
Asian Pac J Cancer Prev. 2011;12(8):1909-16.
4
Health treaty dilution: a case study of Japan's influence on the language of the WHO Framework Convention on Tobacco Control.健康条约淡化:以日本对《世界卫生组织烟草控制框架公约》措辞的影响为例的研究
J Epidemiol Community Health. 2006 Sep;60(9):751-6. doi: 10.1136/jech.2005.043794.
5
Courtesy and the challenges of implementing smoke-free policies in Japan.日本的礼貌与实施无烟政策面临的挑战。
Nicotine Tob Res. 2006 Apr;8(2):203-16. doi: 10.1080/14622200600576297.
6
Tobacco industry manipulation of research.烟草行业对研究的操纵。
Public Health Rep. 2005 Mar-Apr;120(2):200-8. doi: 10.1177/003335490512000215.
7
The limits of competing interest disclosures.利益冲突披露的局限性。
Tob Control. 2005 Apr;14(2):118-26.
8
How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.菲利普·莫里斯如何打开日本香烟市场:全球烟草控制的经验教训
Tob Control. 2004 Dec;13(4):379-87. doi: 10.1136/tc.2004.008441.
9
Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.向菲利普·莫里斯公司学习:从美国烟草行业的内部文件看日本烟草公司应对烟草对健康危害证据的策略
Lancet. 2004 May 29;363(9423):1820-4. doi: 10.1016/S0140-6736(04)16310-1.
10
Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98.1960 - 1998年加利福尼亚人前瞻性研究中的环境烟草烟雾与烟草相关死亡率
BMJ. 2003 May 17;326(7398):1057. doi: 10.1136/bmj.326.7398.1057.